TALEN

TALEN1-gfi1aa

ID
ZDB-TALEN-230428-1
Name
TALEN1-gfi1aa
Previous Names
None
Target
Target Sequence 1
5' - CAGTCTTCTCAACAGT - 3'
ZFIN BLAST NCBI BLAST Ensembl
Target Sequence 2
5' - CACACACACTGCCCT - 3'
ZFIN BLAST NCBI BLAST Ensembl
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
szy5 gfi1aa
Expression
Gene expression in Wild Types + TALEN1-gfi1aa
No data available
Phenotype
Phenotype resulting from TALEN1-gfi1aa
No data available
Phenotype of all Fish created by or utilizing TALEN1-gfi1aa
Phenotype Fish Conditions Figures
vasculature development increased process quality, abnormal gfi1aaszy5/szy5 standard conditions FIGURE 2 with image,  FIGURE 3 with image from Wu et al., 2022
neutrophil mpx expression increased amount, abnormal gfi1aaszy5/szy5 standard conditions Fig 4 with image from Gao et al., 2021
Fig. 1 with image,  Fig. 4 with image from Wu et al., 2021
erythroid lineage cell tfr1a expression decreased amount, abnormal gfi1aaszy5/szy5 standard conditions FIGURE 1 with image from Wu et al., 2022
neutrophil differentiation increased frequency, abnormal gfi1aaszy5/szy5 standard conditions Fig 4 with image from Gao et al., 2021
erythroid lineage cell histone H3K4 demethylase activity decreased process quality, abnormal gfi1aaszy5/szy5 standard conditions FIGURE 5 with image from Wu et al., 2022
endothelial cell kdrl expression increased amount, abnormal gfi1aaszy5/szy5 standard conditions FIGURE 4 with image,  FIGURE 5 with image from Wu et al., 2022
neutrophil lyz expression increased amount, abnormal gfi1aaszy5/szy5 standard conditions Fig. 1 with image,  Fig. 4 with image from Wu et al., 2021
endothelial cell clec14a expression increased amount, abnormal gfi1aaszy5/szy5 standard conditions FIGURE 2 with image from Wu et al., 2022
erythroid lineage cell sptb expression decreased amount, abnormal gfi1aaszy5/szy5 standard conditions FIGURE 1 with image from Wu et al., 2022
erythroid lineage cell epb41b expression decreased amount, abnormal gfi1aaszy5/szy5 standard conditions FIGURE 1 with image from Wu et al., 2022
endothelial cell cdh5 expression increased amount, abnormal gfi1aaszy5/szy5 standard conditions FIGURE 2 with image from Wu et al., 2022
endothelial cell egfl7 expression increased amount, abnormal gfi1aaszy5/szy5 standard conditions FIGURE 2 with image from Wu et al., 2022
erythroid lineage cell alas2 expression decreased amount, abnormal gfi1aaszy5/szy5 standard conditions FIGURE 1 with image,  FIGURE 4 with image,  FIGURE 5 with image from Wu et al., 2022
endothelial cell flt4 expression increased amount, abnormal gfi1aaszy5/szy5 standard conditions FIGURE 2 with image from Wu et al., 2022
endothelial cell sox7 expression increased amount, abnormal gfi1aaszy5/szy5 standard conditions FIGURE 2 with image from Wu et al., 2022
erythroid lineage cell transcriptional attenuation decreased process quality, abnormal gfi1aaszy5/szy5 standard conditions FIGURE 3 with image from Wu et al., 2022
erythroid lineage cell gata1a expression decreased amount, abnormal gfi1aaszy5/szy5 standard conditions FIGURE 1 with image from Wu et al., 2022
erythroid lineage cell hbbe3 expression decreased amount, abnormal gfi1aaszy5/szy5 standard conditions FIGURE 1 with image from Wu et al., 2022
erythroid lineage cell hbae3 expression decreased amount, abnormal gfi1aaszy5/szy5 standard conditions FIGURE 1 with image from Wu et al., 2022
endothelial cell development increased process quality, abnormal gfi1aaszy5/szy5 standard conditions FIGURE 2 with image from Wu et al., 2022
blood neutrophil increased amount, abnormal gfi1aaszy5/szy5; i114Tg/i114Tg standard conditions Fig. 7 with image from Wu et al., 2021
mature neutrophil decreased amount, abnormal gfi1aaszy5/szy5; i114Tg/i114Tg standard conditions Fig. 2 with image,  Fig. 7 with image from Wu et al., 2021
blood monocyte increased amount, abnormal gfi1aaszy5/szy5; i114Tg/i114Tg standard conditions Fig. 7 with image from Wu et al., 2021
neutrophil progenitor cell cell division increased frequency, abnormal gfi1aaszy5/szy5; i114Tg/i114Tg standard conditions Fig. 2 with image from Wu et al., 2021
neutrophil progenitor cell increased amount, abnormal gfi1aaszy5/szy5; i114Tg/i114Tg standard conditions Fig. 2 with image,  Fig. 7 with image from Wu et al., 2021
neutrophil GFP expression increased amount, abnormal gfi1aaszy5/szy5; i114Tg/i114Tg standard conditions Fig. 2 with image from Wu et al., 2021
head kidney common myeloid progenitor increased amount, abnormal gfi1aaszy5/szy5; i114Tg/i114Tg standard conditions Fig. 7 with image from Wu et al., 2021
head kidney myeloid cell increased amount, abnormal gfi1aaszy5/szy5; i114Tg/i114Tg standard conditions Fig. 7 with image from Wu et al., 2021
neutrophil cebpa expression increased amount, abnormal gfi1aaszy5/szy5; i114Tg/i114Tg standard conditions Fig. 3 with image from Wu et al., 2021
neutrophil proteasomal protein catabolic process decreased process quality, abnormal gfi1aaszy5/szy5 + MO1-irf2bp2a standard conditions Fig 4 with image from Gao et al., 2021
neutrophil differentiation increased frequency, abnormal gfi1aaszy5/szy5 + MO1-irf2bp2a standard conditions Fig 4 with image from Gao et al., 2021
neutrophil mpx expression increased amount, abnormal gfi1aaszy5/szy5 + MO1-irf2bp2a standard conditions Fig 4 with image from Gao et al., 2021
neutrophil regulation of ubiquitin protein ligase activity decreased process quality, abnormal gfi1aaszy5/szy5 + MO1-irf2bp2a standard conditions Fig 4 with image from Gao et al., 2021
erythroid lineage cell alas2 expression amount, ameliorated gfi1aaszy5/szy5 + MO2-etsrp standard conditions FIGURE 4 with image from Wu et al., 2022
endothelial cell kdrl expression amount, ameliorated gfi1aaszy5/szy5 + MO2-etsrp standard conditions FIGURE 4 with image from Wu et al., 2022
erythroid lineage cell alas2 expression amount, ameliorated gfi1aaszy5/szy5 + MO5-sox7 standard conditions FIGURE 4 with image from Wu et al., 2022
endothelial cell kdrl expression amount, ameliorated gfi1aaszy5/szy5 + MO5-sox7 standard conditions FIGURE 4 with image from Wu et al., 2022
erythroid lineage cell alas2 expression amount, ameliorated gfi1aaszy5/szy5 + MO2-etsrp + MO5-sox7 standard conditions FIGURE 4 with image from Wu et al., 2022
endothelial cell kdrl expression amount, ameliorated gfi1aaszy5/szy5 + MO2-etsrp + MO5-sox7 standard conditions FIGURE 4 with image from Wu et al., 2022
neutrophil lyz expression amount, ameliorated gfi1aaszy5/szy5; cebpahkz7/+ standard conditions Fig. 4 with image from Wu et al., 2021
neutrophil mpx expression amount, ameliorated gfi1aaszy5/szy5; cebpahkz7/+ standard conditions Fig. 4 with image from Wu et al., 2021
neutrophil mpx expression decreased amount, abnormal gfi1aaszy5/szy5; cebpahkz7/hkz7 standard conditions Fig. 4 with image from Wu et al., 2021
neutrophil lyz expression decreased amount, abnormal gfi1aaszy5/szy5; cebpahkz7/hkz7 standard conditions Fig. 4 with image from Wu et al., 2021
endothelial cell clec14a expression increased amount, abnormal gfi1aaszy5/szy5; gfi1abszy10/szy10 standard conditions FIGURE 2 with image from Wu et al., 2022
erythroid lineage cell tfr1a expression decreased amount, abnormal gfi1aaszy5/szy5; gfi1abszy10/szy10 standard conditions FIGURE 1 with image from Wu et al., 2022
erythroid lineage cell sptb expression decreased amount, abnormal gfi1aaszy5/szy5; gfi1abszy10/szy10 standard conditions FIGURE 1 with image from Wu et al., 2022
endothelial cell cdh5 expression increased amount, abnormal gfi1aaszy5/szy5; gfi1abszy10/szy10 standard conditions FIGURE 2 with image from Wu et al., 2022
endothelial cell sox7 expression increased amount, abnormal gfi1aaszy5/szy5; gfi1abszy10/szy10 standard conditions FIGURE 2 with image from Wu et al., 2022
erythroid lineage cell epb41b expression decreased amount, abnormal gfi1aaszy5/szy5; gfi1abszy10/szy10 standard conditions FIGURE 1 with image from Wu et al., 2022
endothelial cell flt4 expression increased amount, abnormal gfi1aaszy5/szy5; gfi1abszy10/szy10 standard conditions FIGURE 2 with image from Wu et al., 2022
endothelial cell egfl7 expression increased amount, abnormal gfi1aaszy5/szy5; gfi1abszy10/szy10 standard conditions FIGURE 2 with image from Wu et al., 2022
erythroid lineage cell alas2 expression decreased amount, abnormal gfi1aaszy5/szy5; gfi1abszy10/szy10 standard conditions FIGURE 1 with image from Wu et al., 2022
erythroid lineage cell hbae3 expression decreased amount, abnormal gfi1aaszy5/szy5; gfi1abszy10/szy10 standard conditions FIGURE 1 with image from Wu et al., 2022
erythroid lineage cell hbbe3 expression decreased amount, abnormal gfi1aaszy5/szy5; gfi1abszy10/szy10 standard conditions FIGURE 1 with image from Wu et al., 2022
endothelial cell clec14a expression increased amount, abnormal gfi1aaszy5/szy5; gfi1bszy9/szy9 standard conditions FIGURE 2 with image from Wu et al., 2022
erythroid lineage cell tfr1a expression decreased amount, abnormal gfi1aaszy5/szy5; gfi1bszy9/szy9 standard conditions FIGURE 1 with image from Wu et al., 2022
erythroid lineage cell sptb expression decreased amount, abnormal gfi1aaszy5/szy5; gfi1bszy9/szy9 standard conditions FIGURE 1 with image from Wu et al., 2022
endothelial cell sox7 expression increased amount, abnormal gfi1aaszy5/szy5; gfi1bszy9/szy9 standard conditions FIGURE 2 with image from Wu et al., 2022
endothelial cell cdh5 expression increased amount, abnormal gfi1aaszy5/szy5; gfi1bszy9/szy9 standard conditions FIGURE 2 with image from Wu et al., 2022
erythroid lineage cell epb41b expression decreased amount, abnormal gfi1aaszy5/szy5; gfi1bszy9/szy9 standard conditions FIGURE 1 with image from Wu et al., 2022
endothelial cell flt4 expression increased amount, abnormal gfi1aaszy5/szy5; gfi1bszy9/szy9 standard conditions FIGURE 2 with image from Wu et al., 2022
erythroid lineage cell alas2 expression decreased amount, abnormal gfi1aaszy5/szy5; gfi1bszy9/szy9 standard conditions FIGURE 1 with image from Wu et al., 2022
endothelial cell egfl7 expression increased amount, abnormal gfi1aaszy5/szy5; gfi1bszy9/szy9 standard conditions FIGURE 2 with image from Wu et al., 2022
erythroid lineage cell hbae3 expression decreased amount, abnormal gfi1aaszy5/szy5; gfi1bszy9/szy9 standard conditions FIGURE 1 with image from Wu et al., 2022
erythroid lineage cell hbbe3 expression decreased amount, abnormal gfi1aaszy5/szy5; gfi1bszy9/szy9 standard conditions FIGURE 1 with image from Wu et al., 2022
endothelial cell flt4 expression increased amount, abnormal gfi1aaszy5/szy5; gfi1abszy10/szy10; gfi1bszy9/szy9 standard conditions FIGURE 2 with image from Wu et al., 2022
endothelial cell cdh5 expression increased amount, abnormal gfi1aaszy5/szy5; gfi1abszy10/szy10; gfi1bszy9/szy9 standard conditions FIGURE 2 with image from Wu et al., 2022
erythroid lineage cell tfr1a expression decreased amount, abnormal gfi1aaszy5/szy5; gfi1abszy10/szy10; gfi1bszy9/szy9 standard conditions FIGURE 1 with image from Wu et al., 2022
erythroid lineage cell alas2 expression decreased amount, abnormal gfi1aaszy5/szy5; gfi1abszy10/szy10; gfi1bszy9/szy9 standard conditions FIGURE 1 with image from Wu et al., 2022
erythroid lineage cell hbbe3 expression decreased amount, abnormal gfi1aaszy5/szy5; gfi1abszy10/szy10; gfi1bszy9/szy9 standard conditions FIGURE 1 with image from Wu et al., 2022
erythroid lineage cell hbae3 expression decreased amount, abnormal gfi1aaszy5/szy5; gfi1abszy10/szy10; gfi1bszy9/szy9 standard conditions FIGURE 1 with image from Wu et al., 2022
endothelial cell clec14a expression increased amount, abnormal gfi1aaszy5/szy5; gfi1abszy10/szy10; gfi1bszy9/szy9 standard conditions FIGURE 2 with image from Wu et al., 2022
endothelial cell egfl7 expression increased amount, abnormal gfi1aaszy5/szy5; gfi1abszy10/szy10; gfi1bszy9/szy9 standard conditions FIGURE 2 with image from Wu et al., 2022
endothelial cell sox7 expression increased amount, abnormal gfi1aaszy5/szy5; gfi1abszy10/szy10; gfi1bszy9/szy9 standard conditions FIGURE 2 with image from Wu et al., 2022
erythroid lineage cell epb41b expression decreased amount, abnormal gfi1aaszy5/szy5; gfi1abszy10/szy10; gfi1bszy9/szy9 standard conditions FIGURE 1 with image from Wu et al., 2022
erythroid lineage cell sptb expression decreased amount, abnormal gfi1aaszy5/szy5; gfi1abszy10/szy10; gfi1bszy9/szy9 standard conditions FIGURE 1 with image from Wu et al., 2022
Citations
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.